Application of NSAIDs in the treatment of pulmonary diseases- a comparative study of the therapeutic & the adverse impacts

Application of NSAIDs in the treatment of pulmonary diseases- a comparative study of the therapeutic & the adverse impacts

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2019.

Détails bibliographiques
Auteur principal:	Rahman, Farhana
Autres auteurs:	Afrose, Afrina
Format:	Thèse
Langue:	English
Publié:	Brac University 2021
Sujets:	NSAIDs Pulmonary diseases Pulmonary administration Therapeutic effectiveness Adverse impacts Better & safe treatment opportunities Lungs > Diseases
Accès en ligne:	http://hdl.handle.net/10361/14396

Documents similaires

Different approaches in the treatment of obstructive pulmonary diseases
par: Kabir, Eva Rahman, et autres
Publié: (2016)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
par: Rithin, Rafia Islam
Publié: (2022)

Patients' compliance in pulmonary drug delivery systems in Mirpur
par: Faruqe, Abdullah Al
Publié: (2021)

Prevalence and risk factors of chronic obstructive pulmonary disease in Bangladesh: A systematic review
par: Sutradhar, Ipsita, et autres
Publié: (2022)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
par: Shabnam, Musharrat
Publié: (2018)

Evaluation of three immunological tests for the diagnosis of pulmonary tuberculosis in a rural endemic area of Bangladesh
par: Islam, Mohammad Tariqul, et autres
Publié: (2016)

Occupational Pulmonary Tuberculosis among BRAC Community Health Workers of Trishal, Bangladesh
par: Karim, Fazlul, et autres
Publié: (2019)

Therapeutic and adverse effects of SSRIs
par: Rahman, Imtiazur
Publié: (2018)

Lost in care pathway: a qualitative investigation on the health system delay of extra pulmonary tuberculosis patients in Bangladesh
par: Sarker, Malabika, et autres
Publié: (2018)

A short review on additional therapeutic effects and adverse effects of sedative and hypnotic drugs
par: Tisha, Sadia Sultana
Publié: (2021)

A brief survey on the effect of smoke of different sources on COPD patients
par: Nawal, Nusrat
Publié: (2021)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
par: Onanna, Kazi
Publié: (2024)

Prevalence of Tuberculosis and associated factors in Sylhet, Bangladesh
par: Ara, Effat
Publié: (2021)

The adverse impact on the project by facade package
par: BUCG
Publié: (2023)

Barriers to oral and inhaled drug delivery: a review
par: Kamal, Farhana
Publié: (2023)

An overview on Covid-19 and invention of its treatment by drugs
par: Nawer, Anika
Publié: (2022)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
par: Rahman, Tasnim
Publié: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
par: Islam, Md. Irfath
Publié: (2023)

Potential of liposomes for the treatment of lung cancer- a review
par: Mim, Shanzida
Publié: (2023)

A review on recent advances in drugs for lung cancer treatment
par: Noor, Fouzia
Publié: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
par: Afsana, Nourin
Publié: (2022)

Treatment regimens of urinary bladder adenocarcinoma
par: Tarafder, Ayndrila
Publié: (2024)

A review on the pathophysiology and potential drugs for Covid-19
par: Modak, Srijani
Publié: (2022)

Use of nano-emulsion for delivery of NSAID
par: Khatun, Hafiza
Publié: (2021)

Treatment options of Parkinson’s disease: How far we are from the cure?
par: Afreen, Nuraia
Publié: (2021)

A comprehensive review on drug repurposing in cancer treatment
par: Sarkar, Onusree
Publié: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Flora, Sanzida Alam
Publié: (2024)

Implications of unusual non-coding RNAs in human diseases
par: Ahmed, Tazkia
Publié: (2021)

Exploring the potential of organic molecules in the treatment of covid-19
par: Mondol, Winifred Claire
Publié: (2024)

Stem cells as therapeutic carrier in cancer treatment
par: Anika, Mysha Yeasmin
Publié: (2022)

A review on targeted therapies for lung cancer
par: Ashraf, Anushey
Publié: (2023)

Antimicrobial peptides in skin diseases
par: Pinkey, Monika Tabassum
Publié: (2022)

Biologics and Biosimilars as Treatment Options for Psoriasis
par: Moya, Amena Khatun
Publié: (2023)

Medications used for covid-19 treatment and a comparison of their mechanism of action and therapeutic efficacy
par: Sultana, Sadia
Publié: (2023)

Vitamin C and the common cold /
par: Pauling, Linus, 1901-1994
Publié: (1970)

Evaluation of wound healing using a combination therapy of NSAID and an antioxidant on mice model
par: Biswas, Raisa Prapti
Publié: (2018)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
par: F. S. Amaral, André, et autres
Publié: (2017)

Evaluation of endometriosis risk factors, symptoms, and clinical treatments in Bangladesh: a cross-sectional study
par: Afrose, Afsana
Publié: (2024)

PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
par: Lubaba, Anikah
Publié: (2024)

Antimicrobial peptides in the treatment of dermatosis
par: Hussain, Sumaya Binty
Publié: (2024)